Cisplatin and acute tubular necrosis

Clinical Oncology

Volumn 9, Issue 4, 1997, Pages 267-268

  Wadd, N J ^a   Tiplady, C ^a   Roberts, J T ^a  

^a NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

Author keywords

Acute tubular necrosis; Cisplatin; Malignant teratoma; Salt losing neuropathy

Indexed keywords

ANTINEOPLASTIC METAL COMPLEX; CISPLATIN;

ACUTE KIDNEY TUBULE NECROSIS; ADULT; ARTICLE; CASE REPORT; HUMAN; MALE; MALIGNANT TERATOMA; POLYURIA; PRIORITY JOURNAL; SALT LOSING NEPHRITIS;

EID: 0030801818     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0936-6555(97)80016-7     Document Type: Article

References (9)

1. Gonzales-Vitale JC, Hayes DM, Cvitkovic E, et al. The renal pathology in clinical trials of cisplatin(ii)diamminodichloride. Cancer 1977;30:1451-6.
2. Kanaka C, Oetliker OH, Bianchetti MG. Chronic cisplatin tubulopathy in humans and animals: clear-cut discrepant findings. Nephron 1991;59:693.
3. Daugaard G, Abildgaard U, Holstein-Rathlou N, et al. Renal tubular function inpatients treated with high dose cisplatin. Clin Pharmacol Ther 1988;44:164-72.
4. Verplanke AJW, Herber RFM, de Vit R, et al. Comparison of renal function parameters in the assessment of cisplatin induced nephrotoxicity. Nephron 1994;66:267-72.
5. Wong NLM, Walker VR, Wong EFC, et al. Mechanism of polyuria after cisplatin therapy. Nephron 1993;65:623-7.
6. Lammers PJ, White L, Ettinger LJ. Cisplatinum induced renal sodium wasting. Med Pediatr Oncol 1984;12:343-6.
7. Kurtzberg J, Dennis VW, Kinney TR. Cisplatin induced renal salt wasting. Med Pediatr Oncol 1984;12:150-4.
8. Marriette X, Paule B, Bennet P, et al. Cisplatin and hyponatremia. Ann Intern Med 1988;108:770-1.
9. Hutchinson FN, Perez EA, Gandara DR, et al. Renal salt wasting in patients treated with cisplatin. Ann Intern Med 1988;108:21-5.